TEAS Plus New Application

STELLA

Curio Digital Therapeutics Inc

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90499207
Filing Date: 01/30/2021

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK Stella
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT Stella
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Curio Digital Therapeutics Inc
DBA/AKA/TA/FORMERLY DBA Curio Digital Therapeutics Inc
INTERNAL ADDRESS 100 Overlook Drive Floor 2 Princeton NJ
*MAILING ADDRESS 100 Overlook Drive Floor 2 Princeton NJ
*CITY Princeton
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
08540
PHONE 267-629-9674
*EMAIL ADDRESS XXXX
WEBSITE ADDRESS http://curiodigitaltx.com/
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 042 
*IDENTIFICATION Computer programming in the medical field; Consulting services in the field of providing online, non-downloadable software and applications; Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research in the field of behavioral health problems in various life stages of women; Medical and scientific research information in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research information in the field of behavioral health problems in various life stages of women; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development in the field of prescription drug consulting software; Research and development in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Research and development of computer software; Research and development of new products; Research and development of technology in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements; Research and development of technology in the field of prescription of therapeutic exercise programs; Research in the field of Prescription drug consulting software; Research in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Compiling data for research purposes in the field of medical science and medical consultancy; Computer software consulting; Providing medical research and scientific research information in the field of oncology via the Internet; Providing a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents regardless of medical organization or geographic location; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical research; Providing information about medical research via a website; Providing information about medical and scientific research; Providing information about medical and scientific research via a website; Scientific research; Scientific research consulting in the field of prescription digital therapeutics targeting serious medical conditions; Scientific research consulting in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Technical research in the field of pharmaceutical studies; Technology research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Technology research in the field of behavioral health problems in various life stages of women
*FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 07/07/2020
       FIRST USE IN COMMERCE DATE At least as early as 07/07/2020
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-240940632093291ccc10 459713d647f9-202101300255 28661522_._Specimen_Stell a.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\904\992\90499207\xml1\ FTK0003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\904\992\90499207\xml1\ FTK0004.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\904\992\90499207\xml1\ FTK0005.JPG
       SPECIMEN DESCRIPTION Webpage
        WEBPAGE URL http://curiodigitaltx.com/
        WEBPAGE DATE OF ACCESS 01/29/2021
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
CORRESPONDENCE INFORMATION
NAME Curio Digital Therapeutics Inc
DOCKET/REFERENCE NUMBER 3075
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE desk@patentwire.co.in
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) utkarsh@patentwire.co.in; sid@curiodigitaltx.com; k.shruti@patentwire.co.in; shailja@curiodigitaltx.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Shailja Dixit/
* SIGNATORY'S NAME Shailja Dixit
* SIGNATORY'S POSITION CEO
SIGNATORY'S PHONE NUMBER 267-629-9674
* DATE SIGNED 01/30/2021
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90499207
Filing Date: 01/30/2021

To the Commissioner for Trademarks:

MARK: Stella (Standard Characters, see mark)
The literal element of the mark consists of Stella. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Curio Digital Therapeutics Inc, DBA Curio Digital Therapeutics Inc, a corporation of Delaware, having an address of
      100 Overlook Drive Floor 2 Princeton NJ
      100 Overlook Drive Floor 2 Princeton NJ
      Princeton, New Jersey 08540
      United States
      267-629-9674(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 042:  Computer programming in the medical field; Consulting services in the field of providing online, non-downloadable software and applications; Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research in the field of behavioral health problems in various life stages of women; Medical and scientific research information in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research information in the field of behavioral health problems in various life stages of women; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development in the field of prescription drug consulting software; Research and development in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Research and development of computer software; Research and development of new products; Research and development of technology in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements; Research and development of technology in the field of prescription of therapeutic exercise programs; Research in the field of Prescription drug consulting software; Research in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Compiling data for research purposes in the field of medical science and medical consultancy; Computer software consulting; Providing medical research and scientific research information in the field of oncology via the Internet; Providing a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents regardless of medical organization or geographic location; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical research; Providing information about medical research via a website; Providing information about medical and scientific research; Providing information about medical and scientific research via a website; Scientific research; Scientific research consulting in the field of prescription digital therapeutics targeting serious medical conditions; Scientific research consulting in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Technical research in the field of pharmaceutical studies; Technology research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Technology research in the field of behavioral health problems in various life stages of women

Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 07/07/2020, and first used in commerce at least as early as 07/07/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Webpage.

Original PDF file:
SPE0-240940632093291ccc10 459713d647f9-202101300255 28661522_._Specimen_Stell a.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3

Webpage URL: http://curiodigitaltx.com/
Webpage Date of Access: 01/29/2021


For informational purposes only, applicant's website address is: http://curiodigitaltx.com/
The applicant's current Correspondence Information:
      Curio Digital Therapeutics Inc
       PRIMARY EMAIL FOR CORRESPONDENCE: desk@patentwire.co.in
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): utkarsh@patentwire.co.in; sid@curiodigitaltx.com; k.shruti@patentwire.co.in; shailja@curiodigitaltx.com
The docket/reference number is 3075.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Shailja Dixit/   Date: 01/30/2021
Signatory's Name: Shailja Dixit
Signatory's Position: CEO
Signatory's Phone Number: 267-629-9674
Signature method: Signed directly within the form
Payment Sale Number: 90499207
Payment Accounting Date: 02/01/2021

Serial Number: 90499207
Internet Transmission Date: Sat Jan 30 03:27:00 ET 2021
TEAS Stamp: USPTO/FTK-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20210130032700755986-90499207-
7601990dff976aa24dfc9a2bb505e4e2364c0f02
66bb85f4cafd4678808cbc3751-CC-26580030-2
0210130025528661522

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed